Literature DB >> 8290253

Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.

M F Roussel1, J N Davis, J L Cleveland, J Ghysdael, S W Hiebert.   

Abstract

NIH3T3 cells expressing a mutant colony-stimulating factor-1 receptor (CSF-1R) containing a phenylalanine for tyrosine substitution in the tyrosine kinase domain at codon 809 exhibit defective myc regulation and do not enter S phase when stimulated by CSF-1. Enforced expression of either ets-1 or ets-2 in these cells restores their mitogenic response, albeit less efficiently than myc itself, suggesting that ets proteins may regulate c-myc expression. Ets-1 transactivates reporter genes driven by the human and mouse c-myc promoters through the binding site for the transcription factor E2F, the latter being required for E1A- and serum-induced c-myc expression. Analysis of E2F-1 sequences identified a minimal DNA binding domain that is related to those of ets proteins. Although E2F and ets proteins interact with similar consensus DNA binding sites, in vitro binding assays revealed that E2F can bind DNA as a homodimer, whereas ets proteins bind these sites as monomers. E2F and ets proteins do not form heterodimers in vitro and do not transactivate c-myc synergistically. Thus, E2F-1 and ets family members may independently regulate c-myc transcription through the same binding site at different times following growth factor stimulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8290253

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  37 in total

1.  An E2F-binding site mediates the activation of the proliferative isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase by phosphatidylinositol 3-kinase.

Authors:  Silvia Fernández de Mattos; Eric W-F Lam; Albert Tauler
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

2.  ERF nuclear shuttling, a continuous monitor of Erk activity that links it to cell cycle progression.

Authors:  Lionel Le Gallic; Laura Virgilio; Philip Cohen; Benoit Biteau; George Mavrothalassitis
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

3.  Transcription factor binding and induced transcription alter chromosomal c-myc replicator activity.

Authors:  M Ghosh; G Liu; G Randall; J Bevington; M Leffak
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

4.  Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways.

Authors:  C V Ramana; N Grammatikakis; M Chernov; H Nguyen; K C Goh; B R Williams; G R Stark
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

5.  Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control.

Authors:  Norman G Nagl; Xiaomei Wang; Antonia Patsialou; Michael Van Scoy; Elizabeth Moran
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

6.  The transactivation potential of a c-Myc N-terminal region (residues 92-143) is regulated by growth factor/Ras signaling.

Authors:  M S Colman; M C Ostrowski
Journal:  Nucleic Acids Res       Date:  1996-05-15       Impact factor: 16.971

7.  Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.

Authors:  N Aziz; H Cherwinski; M McMahon
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

8.  EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells.

Authors:  K Tanaka; T Iwakuma; K Harimaya; H Sato; Y Iwamoto
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

9.  Triplex DNA-mediated downregulation of Ets2 expression results in growth inhibition and apoptosis in human prostate cancer cells.

Authors:  Giuseppina M Carbone; Sara Napoli; Alessandra Valentini; Franco Cavalli; Dennis K Watson; Carlo V Catapano
Journal:  Nucleic Acids Res       Date:  2004-08-16       Impact factor: 16.971

10.  Targets of the transcriptional repressor oncoprotein Gfi-1.

Authors:  Zhijun Duan; Marshall Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.